Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
The Lancet. Diabetes & Endocrinology|December 21, 2020
Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control studyCari M Kitahara, Dagrun Slettebø Daltveit, Anders Ekbom, et al.
American Journal of Epidemiology|September 21, 2022
Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry StudyCari M Kitahara, Dagrun Slettebø Daltveit, Anders Ekbom, et al.
International Journal of Cancer|May 9, 2018
Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous womenCamilla Sköld, Tone Bjørge, Anders Ekbom, et al.
BMJ (Clinical Research Ed.)|December 3, 2020
Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adultsDagrun Slettebø Daltveit, Kari Klungsøyr, Anders Engeland, et al.
Acta Oncologica (Stockholm, Sweden)|March 17, 2020
Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington StateAnne Gulbech Ording, Lotte Brix Christensen, Tone Bjørge, et al.
Leukemia & Lymphoma|January 9, 2026
Survival in mantle cell lymphoma patients burdened by a second primary malignancyKossi D Abalo, Trine Trab, Joachim Baech, et al.
International Journal of Cancer|April 29, 2023
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort studyJoshua P Entrop, Caroline E Weibull, Karin E Smedby, et al.
Haematologica|August 30, 2023
MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and <i>TP53</i>/p53 - a Nordic Lymphoma Group studyJoana M Rodrigues, Peter Hollander, Lina Schmidt, et al.
Blood Advances|July 3, 2024
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppressionJoana de Matos Rodrigues, Lavanya Lokhande, Lina M Olsson, et al.
Blood Advances|April 1, 2026
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphomaNinja Övergaard, Kjersti Lia, Jeremia Collin, et al.
Pageof 12